Why Are Aidoc’s AI Tools Winning Over Radiologists?

Clinical decision support startup Aidoc has become a major player in healthcare AI thanks to its focus on acute, life-or-death cases and its R&D-first approach. As Aidoc continues to innovate, Chief Business Officer Tom Valent thinks its commitment to patient safety and transparency will be key contributors to future success. The post Why Are Aidoc’s…

Read More

Journalists Zero In on ‘Certificate of Need’ Laws and Turbulent Obamacare Enrollment Season

KFF Health News senior correspondent Renuka Rayasam discussed gun violence in Bogalusa, Louisiana, on KALW’s Your Call on Dec. 19. Click here to hear Rayasam on Your Call. Read Rayasam’s “Guns, Race, and Profit: The Pain of America’s Other Epidemic,” co-reported with Fred Clasen-Kelly. KFF Health News rural health correspondent Andrew Jones discussed the implications…

Read More

How Kaiser Permanente Consolidated 12 EHRs into 2

Kaiser Permanente consolidated 12 EHR instances across California into two in a matter of hours without disrupting patient care. This project has simplified clinical workflows and improved data consistency, as well as provided a rare example of EHR consolidation executed successfully at scale, said Neil Cowles, the health system’s chief information and technology officer. The…

Read More

BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition

BioMarin Pharmaceutical’s acquisition of Amicus Therapeutics is a marriage of two rare disease biotech companies. Amicus’s two commercialized products, for the enzyme deficiencies Fabry disease and Pompe disease, are each projected to become blockbuster sellers. The post BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition appeared first on MedCity News.

Read More